Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

被引:308
作者
Wilensky, Robert L. [1 ]
Shi, Yi [2 ]
Mohler, Emile R., III [1 ]
Hamamdzic, Damir [1 ]
Burgert, Mark E.
Li, Jun [3 ]
Postle, Anthony [4 ]
Fenning, Robert S. [1 ]
Bollinger, James G. [5 ,6 ]
Hoffman, Bryan E. [3 ]
Pelchovitz, Daniel J. [1 ]
Yang, Jisheng [1 ]
Mirabile, Rosanna C. [3 ]
Webb, Christine L. [3 ]
Zhang, LeFeng [2 ]
Zhang, Ping [2 ]
Gelb, Michael H. [5 ,6 ]
Walker, Max C. [3 ]
Zalewski, Andrew [2 ,3 ]
Macphee, Colin H. [3 ]
机构
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[3] GlaxoSmithKline Inc, King Of Prussia, PA 19406 USA
[4] Southampton Gen Hosp, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England
[5] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[6] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nm.1870
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity is associated with increased risk of cardiac events, but it is not known whether Lp-PLA(2) is a causative agent. Here we show that selective inhibition of Lp-PLA(2) with darapladib reduced development of advanced coronary atherosclerosis in diabetic and hypercholesterolemic swine. Darapladib markedly inhibited plasma and lesion Lp-PLA(2) activity and reduced lesion lysophosphatidylcholine content. Analysis of coronary gene expression showed that darapladib exerted a general anti-inflammatory action, substantially reducing the expression of 24 genes associated with macrophage and T lymphocyte functioning. Darapladib treatment resulted in a considerable decrease in plaque area and, notably, a markedly reduced necrotic core area and reduced medial destruction, resulting in fewer lesions with an unstable phenotype. These data show that selective inhibition of Lp-PLA(2) inhibits progression to advanced coronary atherosclerotic lesions and confirms a crucial role of vascular inflammation independent from hypercholesterolemia in the development of lesions implicated in the pathogenesis of myocardial infarction and stroke.
引用
收藏
页码:1059 / 1066
页数:8
相关论文
共 46 条
[1]   Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease [J].
Aprahamian, T ;
Rifkin, I ;
Bonegio, A ;
Hugel, B ;
Freyssinet, JM ;
Sato, K ;
Castellot, JJ ;
Walsh, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1121-1131
[2]   The identification of clinical candidate SB-480848:: A potent inhibitor of lipoprotein-associated phospholipase A2 [J].
Blackie, JA ;
Bloomer, JC ;
Brown, MJB ;
Cheng, HY ;
Hammond, B ;
Hickey, DMB ;
Ife, RJ ;
Leach, CA ;
Lewis, VA ;
Macphee, CH ;
Milliner, KJ ;
Moores, KE ;
Pinto, IL ;
Smith, SA ;
Stansfield, IG ;
Stanway, SJ ;
Taylor, MA ;
Theobald, CJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) :1067-1070
[3]   Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study [J].
Burke, AP ;
Kolodgie, FD ;
Zieske, A ;
Fowler, DR ;
Weber, DK ;
Varghese, PJ ;
Farb, A ;
Virmani, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1266-1271
[4]   Mildly oxidised LDL induces more macrophage death than moderately oxidised LDL:: roles of peroxidation, lipoprotein-associated phospholipase A2 and PPARγ [J].
Carpenter, KLH ;
Challis, IR ;
Arends, MJ .
FEBS LETTERS, 2003, 553 (1-2) :145-150
[5]   Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease [J].
Caslake, MJ ;
Packard, CJ ;
Suckling, KE ;
Holmes, SD ;
Chamberlain, P ;
Macphee, CH .
ATHEROSCLEROSIS, 2000, 150 (02) :413-419
[6]   Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling - Molecular, cellular, and vascular behavior [J].
Chatzizisis, Yiannis S. ;
Coskun, Ahmet Umit ;
Jonas, Michael ;
Edelman, Elazer R. ;
Feldman, Charles L. ;
Stone, Peter H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (25) :2379-2393
[7]  
Collins R, 2003, LANCET, V361, P2005
[8]   Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein [J].
Davis, Bill ;
Koster, Grielof ;
Douet, Lisa J. ;
Scigelova, Michaela ;
Woffendin, Gary ;
Ward, Joanna M. ;
Smith, Alberto ;
Humphries, Julia ;
Burnand, Kevin G. ;
Macphee, Colin H. ;
Postle, Anthony D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (10) :6428-6437
[9]   Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein [J].
Gardner, Alison A. ;
Reichert, Ethan C. ;
Topham, Matthew K. ;
Stafforini, Diana M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) :17099-17106
[10]  
Garza CA, 2007, MAYO CLIN PROC, V82, P159